<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>10957879</identifier>
<setSpec>0002-5151</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Martínez Aguilar, N E</dc:author>
<dc:author>Martínez Jiménez, N E</dc:author>
<dc:author>Garfias Becerra, J</dc:author>
<dc:author>Rojas Ramos, E</dc:author>
<dc:description xml:lang="en">Apoptosis (cell programmed death) it is a mechanism that implicate a physiological suicide, to keep the cellular homeostasis in big amount of tissues. Fas (APO-1; CD95) system is one of the most important cellular responsible via to induce apoptosis on different tissues. Eosinophillia on peripheral blood and tissues are the main characteristics on allergic like asthma. Eosinophil apoptosis is upper regulated in those diseases by IL-5 y GM-CSF. Corticoids, teophyllin and some macrolids have been used like apoptosis inductors on eosinophills, these could be a novel mechanism to promote a better solution on inflammatory allergic diseases.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:date>2000 Jul-Aug </dc:date>
<dc:title xml:lang="es">Apoptosis en la enfermedad alérgica.</dc:title>
<dc:title xml:lang="en">[Apoptosis in allergic disease].</dc:title>
<dc:publisher>Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)</dc:publisher>
</metadata>
</record>
</pubmed-document>
